Parkman Healthcare Partners’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $2.22M | Sell |
|
|||||
|
2024
Q4 | $4.98M | Sell |
|
|||||
|
2024
Q3 | $24.5M | Buy |
|
|||||
|
2024
Q2 | $9.08M | Buy |
|
|||||
|
2024
Q1 | $11.8M | Sell |
|
|||||
|
2023
Q4 | $14.3M | Buy |
|
|||||
|
2023
Q3 | $9.52M | Buy |
|
|||||
|
2023
Q2 | $11.1M | Buy |
|
|||||
|
2023
Q1 | $7.66M | Buy |
|
|||||
|
2022
Q4 | $6.09M | Buy |
|
|||||
|
2022
Q3 | $3.76M | Buy |
|
|||||
|
2022
Q2 | $1.32M | Sell |
|
|||||
|
2022
Q1 | $3.95M | Buy |
|
|||||
|
2021
Q4 | $4.09M | Buy |
|